|
|
|
Volumn 28, Issue 2, 1996, Pages 974-976
|
|
Clinical use of FK 506 in liver transplantation
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
BILIRUBIN;
CORTICOSTEROID;
CYCLOSPORIN;
LYMPHOCYTE ANTIBODY;
TACROLIMUS;
ADULT;
BILIRUBIN BLOOD LEVEL;
CHILD;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIABETES MELLITUS;
DRUG EFFICACY;
DRUG SAFETY;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
HYPERGLYCEMIA;
IMMUNOSUPPRESSIVE TREATMENT;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
NEPHROTOXICITY;
NEUROTOXICITY;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
CONTROLLED CLINICAL TRIALS;
CYCLOSPORINE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LIVER TRANSPLANTATION;
MULTICENTER STUDIES;
SURVIVAL RATE;
TACROLIMUS;
|
|
EID: 0029918392
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (13)
|
|
References (0)
|
